Eyewash Station Additive Concentrate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 65785-034
  • Package NDC 65785-034-01
  • Application number M018
  • SPL ID 445cd72e-831c-98c4-e063-6294a90a7bdc
  • SPL set ID 362a6b6d-862d-4322-87a8-5b3a07fbe174
  • UNII MOR84MUD8E
  • UNII 6DC9Q167V3

What the source publishes

Labeler
Niagara Pharmaceuticals Inc.
Active ingredients
Chlorhexidine gluconate and Propylene Glycol
Form
LIQUID
Routes
OPHTHALMIC
Administrative status
present-in-source-snapshot
Marketing status
OTC MONOGRAPH DRUG
Product type
HUMAN OTC DRUG
Prescription
Non-prescription

Names this record is found by

Complete source data
us:fda:ndc:65785-034_445cd72e-831c-98c4-e063-6294a90a7bdc
{
  "name": "Eyewash Station Additive Concentrate",
  "splId": "445cd72e-831c-98c4-e063-6294a90a7bdc",
  "labels": [
    {
      "setId": "362a6b6d-862d-4322-87a8-5b3a07fbe174",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=362a6b6d-862d-4322-87a8-5b3a07fbe174",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=362a6b6d-862d-4322-87a8-5b3a07fbe174"
    }
  ],
  "routes": [
    "OPHTHALMIC"
  ],
  "labeler": "Niagara Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": ".236 L in 1 BOTTLE, UNIT-DOSE (65785-034-01)",
      "package_ndc": "65785-034-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20111115"
    }
  ],
  "productId": "65785-034_445cd72e-831c-98c4-e063-6294a90a7bdc",
  "useDomain": "unknown",
  "dosageForm": "LIQUID",
  "productNdc": "65785-034",
  "deaSchedule": null,
  "genericName": "Chlorhexidine gluconate and Propylene Glycol",
  "productType": "HUMAN OTC DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CHLORHEXIDINE GLUCONATE",
      "strength": "145.6 kg/2800L"
    },
    {
      "name": "PROPYLENE GLYCOL",
      "strength": "280 kg/2800L"
    }
  ],
  "applicationNumber": "M018",
  "marketingCategory": "OTC MONOGRAPH DRUG",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20111115",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "non-prescription",
  "harmonizedIdentifiers": {
    "unii": [
      "MOR84MUD8E",
      "6DC9Q167V3"
    ],
    "spl_set_id": [
      "362a6b6d-862d-4322-87a8-5b3a07fbe174"
    ],
    "manufacturer_name": [
      "Niagara Pharmaceuticals Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:65785-034_445cd72e-831c-98c4-e063-6294a90a7bdc"